F.D.A. Panel Recommends Pfizer Boosters for Those Over 65 or at Risk

The committee said there was insufficient evidence to recommend third shots for all adult recipients of the vaccine, as Pfizer had requested.The committee said there was insufficient evidence to recommend third shots for all adult recipients of the vaccine, as Pfizer had requested.Coronavirus (2019-nCoV), Vaccination and Immunization, Food and Drug Administration, Centers for Disease Control and Prevention, National Institutes of Health, Pfizer Inc, Moderna Inc, Preventive Medicine, United States Politics and Government, United StatesRead More

Leave a Reply

Your email address will not be published.